Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1973;43(4):385–392. doi: 10.1007/BF01556156

The behaviour in vitro of attenuated recombinant influenza viruses

S R Mostow 1,✉, D A J Tyrrell 1
PMCID: PMC7086870  PMID: 4799157

Summary

Influenza strains produced by recombination and tested as possible live vaccine candidates were studied in organ cultures of trachea. Two strains which proved to be too virulent in human volunteers regularly caused damage to the ciliated epithelium and viruses grew to high titre. Two strains which proved to be attenuated for volunteers did not cause appreciable damage, although they replicated to low titre in the epithelium. Similar results were obtained with influenza A virus attenuated by passage in the presence of horse sera. The method may be of value for detecting virulent live influenza vaccine candidates without risking severe illness in volunteers.

Keywords: Influenza, Influenza Virus, Influenza Vaccine, Severe Illness, Vaccine Candidate

References

  1. Beare A. S., Bynoe M. L. Attenuation of human influenza A viruses. Brit. med. J. 1969;4:198–201. doi: 10.1136/bmj.4.5677.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beare A. S., Hall T. S. Recombinant influenza A viruses as live vaccines for man. Lancet. 1971;ii:1271–1273. doi: 10.1016/s0140-6736(71)90597-6. [DOI] [PubMed] [Google Scholar]
  3. Cherry J. D., Taylor-Robinson D. Large quantity production of chicken embryo trachea organ cultures for use of virus and mycoplasma studies. Appl. Microbiol. 1970;19:658–662. doi: 10.1128/am.19.4.658-662.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harnett G. B., Hooper W. L. Test tube organ cultures of ciliated epithelium for the isolation of respiratory viruses. Lancet. 1968;i:339–340. doi: 10.1016/s0140-6736(68)90800-3. [DOI] [PubMed] [Google Scholar]
  5. Hoorn B., Tyrrell D. A. J. Organ cultures in virology. Progr. med. Virol. 1969;11:408–450. [PubMed] [Google Scholar]
  6. Kilbourne E. D. Future influenza vaccines and the use of genetic recombinants. Bull. Wrld Hlth Org. 1969;41:643–645. [PMC free article] [PubMed] [Google Scholar]
  7. Leibovitz A. The growth and maintenance of tissue-cell cultures in free gas exchange with the atmosphere. Amer. J. Hyg. 1963;78:173–180. doi: 10.1093/oxfordjournals.aje.a120336. [DOI] [PubMed] [Google Scholar]
  8. McCahon D., Schild G. C. Segregation of antigenic and biological characteristics during influenza virus recombination. J. gen. Virol. 1972;15:73–77. doi: 10.1099/0022-1317-15-1-73. [DOI] [PubMed] [Google Scholar]
  9. Mostow S. R., Tyrrell D. A. J. Detection of attenuation of recombinant influenza virusesin vitro. Lancet. 1972;ii:116–117. doi: 10.1016/s0140-6736(72)91599-1. [DOI] [PubMed] [Google Scholar]
  10. Shaaff D. M., Boswell J., Mufson M. A. Viral and mycoplasmal infections in minor respiratory illnesses and non-streptococcal pharyngitis. A search for coronaviruses using foetal trachea organ cultures. Amer. Rev. resp. Dis. 1971;104:41–51. doi: 10.1164/arrd.1971.104.1.41. [DOI] [PubMed] [Google Scholar]
  11. Schoenbaum S. C., Mostow S. R., Dowdle W. R., Coleman M. T., Kaye H. S. Studies with inactivated influenza vaccines purified by zonal ultracentrifugation. II. Efficacy. Bull. Wrld Hlth Org. 1969;41:531–535. [PMC free article] [PubMed] [Google Scholar]

Articles from Archiv Fur Die Gesamte Virusforschung are provided here courtesy of Nature Publishing Group

RESOURCES